Journal of Gastroenterology High Citation Award
2022年受賞者
Review article
Yuji Eso（Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University）
Microsatellite instability and immune checkpoint inhibitors: toward precision medicine against gastrointestinal and hepatobiliary cancers
J Gastroenterol. 2020; 55: 15–26
Original article
Masato Yoneda（Department of Gastroenterology and Hepatology, Yokohama City University Hospital）
Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: a retrospective nationwide claims database study in Japan
J Gastroenterol. 2021; 56: 1022-1032
Original article
Seiko Hirono（Second Department of Surgery, School of Medicine, Wakayama Medical University）
Recurrence patterns after surgical resection of intraductal papillary mucinous neoplasm （IPMN） of the pancreas; a multicenter, retrospective study of 1074 IPMN patients by the Japan Pancreas Society
J Gastroenterol. 2020; 55: 86–99
Original article
Kazuharu Suzuki（Department of Gastroenterology and Hepatology, Graduate School of Medicine, Hokkaido University）
Tenofovir–disoproxil–fumarate modulates lipid metabolism via hepatic CD36/PPAR-alpha activation in hepatitis B virus infection
J Gastroenterol. 2021; 56: 168–180
2022年 Impact Factor
2021年受賞者
Review article
Masayuki Kitano（Department of Gastroenterology, Wakayama Medical University School of Medicine/Second Department of Internal Medicine, Wakayama Medical University School of Medicine）
Impact of endoscopic ultrasonography on diagnosis of pancreatic cancer
J Gastroenterol. 2019; 54:19-32
Original article
Atsushi Masamune（Division of Gastroenterology, Tohoku University Graduate School of Medicine）
Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2016
J Gastroenterol. 2020; 55:462-470
Original article
Hirayuki Enomoto（Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine）
Transition in the etiology of liver cirrhosis in Japan: a nationwide survey
J Gastroenterol. 2020; 55:353-362
Original article
Susumu Take（Department of Internal Medicine, Fukuwatari Municipal Hospital/Department of Internal Medicine,Nippon Kokan Fukuyama Hospital）
Risk of gastric cancer in the second decade of follow-up after Helicobacter pylori eradication
J Gastroenterol. 2020; 55:281-288
2021年 Impact Factor
2020年受賞者
Review article
Atsushi Mizoguchi（Department of Immunology, Kurume University School of Medicine）
Clinical importance of IL-22 cased in IBD
J Gastroenterol. 2018; 53:465-474
Original article
Ryosuke Tateishi（Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo）
A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011-2015 update
J Gastroenterol. 2019; 54:367-376
Original article
Tomohisa Takagi（Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine/Department for Medical Innovation and Translational Medical Science, Graduate School of Medical Science, Kyoto Prefectural University of Medicineo）
Differences in gut microbiota associated with age, sex, and stool consistency in healthy Japanese subjects
J Gastroenterol. 2019; 54: 53-63
Original article
Kohei Suzuki（Department of Gastroenterology and Hepatology, Graduate School, Tokyo Medical and Dental University）
Single cell analysis of Crohn’s disease patient-derived small intestinal organoids reveals disease activity-dependent modification of stem cell properties
J Gastroenterol. 2018; 53:1035-1047
2020年 Impact Factor
2019年受賞者
Review article
Yoshio Sumida（Division of Hepatology and Pancreatology, Department of Internal Medicine, Aichi Medical University）
Current and future pharmacological therapies for NAFLD/NASH
J Gastroenterol 2018; 53: 362-376
Original article
Kenji Ikeda（Department of Hepatology, Toranomon Hospital）
Phase 2 study of lenvatinib in patients with advanced hepatocellular carcinoma
J Gastroenterol 2017; 52: 512-519
Original article
Kazuaki Chayama（Hiroshima University Hospital）
Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis
J Gastroenterol 2018; 53: 557-565
Original article
Kyohei Nishino（Department of Medicine, Shiga University of Medical Science）
Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease
J Gastroenterol 2018; 53: 95-106
2019年 Impact Factor
